Andrew Witty
From Wikipedia, the free encyclopedia
Andrew Witty is the Chief Executive of GlaxoSmithKline (GSK)[1]. Witty succeeded previous CEO Dr. Jean-Pierre Garnier following his retirement in May 2008.
[edit] References
- ^ GSK (London, 8 Oct, 2007) GlaxoSmithKline appoints Andrew Witty CEO designate retrieved 8 Oct, 2007
Andrew Witty Blog
